View in EDS HTML Full Text PDF Full Text

Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study.

Saved in:
Bibliographic Details
Title: Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study.
Authors: Ghazanfar, Misbah Noshela1 (AUTHOR) misbah.noshela.ghazanfar@regionh.dk, Bartko, Ewa Anna2 (AUTHOR), Arildsen, Nicolai Skovbjerg3 (AUTHOR), Poulsen, Lars K.2 (AUTHOR), Jensen, Bettina Margrethe2 (AUTHOR), Enevold, Christian4 (AUTHOR), Holm, Jesper Grønlund1 (AUTHOR), Woetmann, Anders3 (AUTHOR), Ødum, Niels3 (AUTHOR), Thomsen, Simon Francis1,5 (AUTHOR)
Source: Clinical & Experimental Allergy. May2022, Vol. 52 Issue 5, p715-718. 4p. 2 Graphs.
Database: Environment Complete
Full text is not displayed to guests.
Description
ISSN:09547894
DOI:10.1111/cea.14121